Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Eur J Vasc Endovasc Surg ; 27(2): 193-200, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14718903

ABSTRACT

OBJECTIVES: To assess the current incidence of major lower limb amputations in Southern Finland and epidemiological trends during the last 17 years. MATERIALS AND METHODS: In a retrospective survey for the year 2000 patient data was gathered from hospital records in the eight surgical hospitals in the area studied. Follow-up was 1 year. Amputation data for years 1984-1995 was gathered from reports done before at the same area and amputation figures for years 1990-2001 also from the National Research and Development Centre for Welfare and Health. RESULTS: In year 2000, the incidence of major amputations was 154/million inhabitants. The reason for major amputation was chronic critical lower limb ischaemia in 71.8% and acute ischaemia in 16.5% of the cases. The below-knee (BK)/above-knee (AK) ratio was 0.76. After 1 year only 48% of the patients were alive. From 1984 to 2000 amputation incidence showed a decrease of 41%. The decline in age-adjusted amputation incidence from 1990 to 2000 was 30% and by 2001 as much as 40%. There was a significant inverse correlation both between incidence of infrainguinal bypass and amputation (r=-0.682, p=0.021) and between infrapopliteal bypass and amputation (r=-0.682, p=0.021). CONCLUSIONS: There was a reduction in the number of amputations in Southern Finland during the past 17 years. This occurred synchronously with the increase in vascular reconstructions. Our data suggests that vascular surgery saves patients from BK-amputations and therefore relative amount of AK-amputations inevitably rises.


Subject(s)
Amputation, Surgical/statistics & numerical data , Ischemia/surgery , Aged , Amputation, Surgical/rehabilitation , Amputation, Surgical/trends , Artificial Limbs , Diabetes Mellitus/epidemiology , Finland/epidemiology , Humans , Incidence , Leg/blood supply , Retrospective Studies , Vascular Surgical Procedures
2.
J Vasc Res ; 38(4): 361-9, 2001.
Article in English | MEDLINE | ID: mdl-11455207

ABSTRACT

The behavior of biodegradable polylactide as a stent material has not yet been fully established in small vessels such as arteries with a diameter <3 mm. The aim of this study was to investigate the long-term effect of a copolymeric polylactide (PLA96) stent. Appropriately sized spiral PLA96 stents were implanted into the infrarenal aortas of 20 rabbits. Intraoperative systemic heparinization (150 IU/kg), perioperative subcutaneous enoxaheparin sodium (10 mg), ticlopidine (250 mg/day) for 1 month, and acetosalicylic acid (12.5 mg/day) were continuously administered. Animals were euthanized according to a fixed timetable for up to 34 months for histologic and scanning-electron-microscopic assessment. Endothelialization was complete within 1 month. In 2 of the 3 aortas sampled 3 months after implantation, a mild inflammatory reaction was visible, with no sign of granulomatous or foreign-body reaction in the vessel wall. Instead, in 1 sample examined at the same time point, neointimal chondroid metaplasia was detected. After 6 months, inflammatory reaction declined in the vessel wall. Hydrolyzation of the stent was histologically evident at 12 months, with mild foreign-body reaction detectable in 2 of 5 aortas sampled at this time point. The stent disintegrated without fragmentation by 24 months, as it was gradually replaced by fibrosis. The vessel lumen remained patent at all time points. We conclude that the PLA96 stent degraded with minimal tissue response within 24 months. PLA96 may thus be a promising stent core material for small vessels in the future, although further investigation is needed to establish its final biocompatibility.


Subject(s)
Absorbable Implants , Aorta , Biocompatible Materials , Models, Animal , Polyesters , Stents , Animals , Aorta/pathology , Aorta/physiopathology , Biocompatible Materials/pharmacokinetics , Biodegradation, Environmental , Calcinosis , Endothelium, Vascular/pathology , Endothelium, Vascular/physiopathology , Fibrosis , Foreign-Body Reaction/pathology , Hemosiderin/analysis , Inflammation , Lymphocytes/physiology , Macrophages/physiology , Microscopy, Electron, Scanning , Muscle, Smooth, Vascular/pathology , Polyesters/pharmacokinetics , Rabbits , Time Factors , Vascular Patency
3.
Transpl Int ; 13(3): 218-24, 2000.
Article in English | MEDLINE | ID: mdl-10935706

ABSTRACT

Representative animal models are needed for the study of posttransplant obliterative bronchiolitis (OB). Because human OB originates in terminal bronchi, the validity of tracheal models can be questioned. Using our hetrotopic model, we implanted pieces of a lobar bronchus subcutaneously into domestic pigs. Five groups were included: autograft implants, allograft implants, allograft implants with 2 regimens of cyclosporine (CsA)azathioprine (AZA)-methylprednisolone (MP), and allograft implants with CsA-SDZ RAD-MP. Samples were harvested at 2 weeks and at 1, 2, and 3 months. The histological findings were graded from 0 to 3. Following initial ischemic epithelial damage, autograft implants recovered, but untreated allografts and those treated with CsA-AZA-MP were totally and permanently damaged within one month. In the group treated with CsA-SDZ RAD-MP, a maximal grade 1.5 +/- 0.5 epithelial injury was seen at one month. Epithelial damage preceded and correlated with luminal obliteration. The obliterative lesions histologically resembled human OB. Differences from our previous findings with terminal bronchioles were minor. This study supports the use of larger-size airways in the study of OB.


Subject(s)
Bronchi/transplantation , Bronchiolitis Obliterans/surgery , Immunosuppressive Agents/therapeutic use , Transplantation, Homologous/physiology , Animals , Bronchi/pathology , Cyclosporine/therapeutic use , Disease Models, Animal , Drug Therapy, Combination , Humans , Respiratory Mucosa/drug effects , Respiratory Mucosa/immunology , Respiratory Mucosa/pathology , Swine , Transplantation, Autologous/immunology , Transplantation, Autologous/pathology , Transplantation, Autologous/physiology , Transplantation, Homologous/immunology , Transplantation, Homologous/pathology
4.
Article in English | MEDLINE | ID: mdl-8493499

ABSTRACT

Intrathoracic splenosis is a rare sequel of left thoracoabdominal injury. A case simulating esophageal leiomyoma is presented. As in most earlier cases, the diagnosis was established only at thoracotomy. As splenosis is asymptomatic and may have some beneficial immunologic effects, surgical removal is inadvisable. The 23 previously published cases and the possibility of nonsurgical diagnosis are discussed.


Subject(s)
Choristoma/diagnostic imaging , Esophageal Neoplasms/diagnostic imaging , Leiomyoma/diagnostic imaging , Spleen , Thoracic Neoplasms/diagnostic imaging , Diagnosis, Differential , Female , Humans , Middle Aged , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...